Correlation Between Morningstar Unconstrained and Aequus Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Morningstar Unconstrained and Aequus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Morningstar Unconstrained and Aequus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Morningstar Unconstrained Allocation and Aequus Pharmaceuticals, you can compare the effects of market volatilities on Morningstar Unconstrained and Aequus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Morningstar Unconstrained with a short position of Aequus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Morningstar Unconstrained and Aequus Pharmaceuticals.
Diversification Opportunities for Morningstar Unconstrained and Aequus Pharmaceuticals
0.45 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Morningstar and Aequus is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Morningstar Unconstrained Allo and Aequus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aequus Pharmaceuticals and Morningstar Unconstrained is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Morningstar Unconstrained Allocation are associated (or correlated) with Aequus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aequus Pharmaceuticals has no effect on the direction of Morningstar Unconstrained i.e., Morningstar Unconstrained and Aequus Pharmaceuticals go up and down completely randomly.
Pair Corralation between Morningstar Unconstrained and Aequus Pharmaceuticals
Assuming the 90 days horizon Morningstar Unconstrained is expected to generate 21.35 times less return on investment than Aequus Pharmaceuticals. But when comparing it to its historical volatility, Morningstar Unconstrained Allocation is 28.91 times less risky than Aequus Pharmaceuticals. It trades about 0.18 of its potential returns per unit of risk. Aequus Pharmaceuticals is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest 0.39 in Aequus Pharmaceuticals on November 7, 2024 and sell it today you would earn a total of 0.10 from holding Aequus Pharmaceuticals or generate 25.64% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 82.61% |
| Values | Daily Returns |
Morningstar Unconstrained Allo vs. Aequus Pharmaceuticals
Performance |
| Timeline |
| Morningstar Unconstrained |
| Aequus Pharmaceuticals |
Morningstar Unconstrained and Aequus Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Morningstar Unconstrained and Aequus Pharmaceuticals
The main advantage of trading using opposite Morningstar Unconstrained and Aequus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Morningstar Unconstrained position performs unexpectedly, Aequus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aequus Pharmaceuticals will offset losses from the drop in Aequus Pharmaceuticals' long position.The idea behind Morningstar Unconstrained Allocation and Aequus Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Aequus Pharmaceuticals vs. Ocean Biomedical | Aequus Pharmaceuticals vs. Enveric Biosciences | Aequus Pharmaceuticals vs. Hepion Pharmaceuticals | Aequus Pharmaceuticals vs. Elevation Oncology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |